RedHill Biopharma (RDHL) Operating Leases (2019 - 2026)
RedHill Biopharma (RDHL) reported Operating Leases of $216,000 for the quarter ended Jun 30, 2026, up 0.9% from $214,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Operating Leases (2019 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma posted Operating Leases of $170,000, down 51.8% from the prior year.
- Operating Leases has declined for five consecutive years, with a five-year compound annual growth rate of -37.0% (years ended Dec 2020 to Dec 2025).
- By year, Operating Leases came in at $353,000 in the year ended Dec 31, 2024 (-50.8%), $718,000 in the year ended Dec 31, 2023 (-30.4%), $1.03 million in the year ended Dec 31, 2022 (-36.2%) and $1.62 million in the year ended Dec 31, 2021 (-5.4%).
- The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Operating Leases since the quarter ended Dec 31, 2024.
- Year over year, Operating Leases gained in 1 of the last four quarters, with an average decline of 35.9%.
- The high point for year-over-year Operating Leases in five years was the quarter ended Sep 30, 2021 (growth of 12.7%); the low point was the quarter ended Jun 30, 2024 (a decline of 71.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 859,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Dec 31, 2023 | 455,000.00 |
| Jun 30, 2023 | 994,000.00 |
| Mar 31, 2023 | 979,000.00 |
| Dec 31, 2022 | 6.44 Mn |
| Sep 30, 2022 | 966,000.00 |
| Jun 30, 2022 | 6.67 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 2.57 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 2.98 Mn |
| Mar 31, 2021 | 1.64 Mn |
| Dec 31, 2020 | 3.81 Mn |
| Sep 30, 2020 | 1.55 Mn |
| Jun 30, 2020 | 4.04 Mn |
| Mar 31, 2020 | 1.23 Mn |
API Access
RedHill Biopharma Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();